Disease/Infection News

RSS

WHO Prequalification of IVDs Programme accepts Beckman Coulter’s Aquios CL flow cytometer

Beckman Coulter Life Sciences announce that their Aquios CL flow cytometer has been accepted by the World Health Organization (WHO) Prequalification of In Vitro Diagnostics Programme. It can now be used specifically for the immunologic assessment of patients having, or suspected of having, immune deficiency.

7 Dec 2015

World Hepatitis Alliance highlights need to recognise impact of coinfection between HIV and viral hepatitis

Viral hepatitis is one of the leading causes of non-AIDS-related deaths among people living with HIV, yet often goes undiagnosed. Similar to HIV, the hepatitis B and hepatitis C viruses are blood-borne, having similar transmission routes like sexual contact for hepatitis B and injection drug use and sexual contact for hepatitis C.

7 Dec 2015

Bacteriophage therapy: an alternative to antibiotics? An interview Professor Clokie

A phage is a virus that infects a bacterium. People often get very confused about what the difference is between a virus and a bacterium. A virus, like a bacterium, is also a microorganism, but unlike bacteria, it needs to have a host to be able to replicate and propagate.

2 Dec 2015

Larger portion of Africa at high risk for malaria transmission

A larger portion of Africa is currently at high risk for malaria transmission than previously predicted, according to a new University of Florida mapping study.

1 Dec 2015

Synthetic Biologics announces positive results from first SYN-004 Phase 2a study for prevention of CDI, AAD

Synthetic Biologics, Inc.), a clinical stage company focused on developing therapeutics to protect the gut microbiome while targeting pathogen specific diseases, announced positive topline results from the first Phase 2a study of SYN-004, the Company's candidate designed to protect the gut microbiome from the unintended effects of certain commonly used intravenous (IV) beta-lactam antibiotics for the prevention C. difficile infection (CDI) and antibiotic-associated diarrhea (AAD).

1 Dec 2015

Novel class of antimicrobials could be effective in fighting drug-resistant MRSA infection

A novel class of antimicrobials that inhibits the function of a key disease-causing component of bacteria could be effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of the major drug-resistant bacterial pathogens, according to researchers at Georgia State University.

1 Dec 2015

Researchers develop novel computational approach to accelerate search for hepatitis C vaccine

Borrowing from several statistical science models, an interdisciplinary team of researchers from the University of Illinois at Urbana-Champaign has developed a novel computational approach for massively accelerating the search for a hepatitis C vaccine.

1 Dec 2015

Research highlights importance of controlling hospital and nursing home infection

A Rhode Island Hospital and The Miriam Hospital study found that a small percentage of nursing home patients carrying multi drug-resistant bacteria are admitted to hospitals without showing symptoms caused by the bacteria. The research, published in the American Journal of Infection Control, highlights the importance of hospital and nursing home infection control practices.

1 Dec 2015

Combination of antiviral medications can eradicate HCV infection in patients with advanced liver disease

A large multi-center clinical trial has found that a combination of antiviral medications can eradicate hepatitis C infection in more than 90 percent of patients with advanced liver disease. Known as the ASTRAL-4 trial, the study was co-led by investigators at Beth Israel Deaconess Medical Center and Intermountain Medical Center and published online Nov. 17 in The New England Journal of Medicine.

1 Dec 2015

Innovative compound with anti-MRSA qualities may help develop new class of antibiotics

With global health services increasingly worried about the rise of antibiotic resistant diseases, researchers at Maynooth University have discovered a compound whose anti-MRSA qualities pave the way for the development of a new class of antibiotics.

1 Dec 2015

WHO recommends new strategies to treat HIV patients, reduce new infections

The world is poised to end the AIDS epidemic by 2030 – provided it can accelerate the pace of progress achieved globally over the past 15 years, according to a new World Health Organization (WHO) report.

1 Dec 2015

Asia-Pacific adolescents face higher risk of HIV, account for 15% of new infections

The Asia-Pacific region is facing a ‘hidden epidemic’ of HIV among adolescents. There were an estimated 50,000 new HIV infections among adolescents aged 15-19 in 2014, accounting for 15 per cent of new infections.

1 Dec 2015

Scientists can accurately measure microbial growth rates inside gastrointestinal tracts

For the first time, scientists can accurately measure population growth rates of the microbes that live inside mammalian gastrointestinal tracts, according to a new method reported in Nature Communications by a team at the Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard Medical School.

1 Dec 2015

MPP collaborates with University of Liverpool to accelerate development of HIV nanomedicines

The Medicines Patent Pool today announced a collaboration with the University of Liverpool and a licence for the university's Solid Drug Nanoparticle (SDN) technology to accelerate the development of WHO-recommended antiretrovirals as nanomedicines.

30 Nov 2015

Seaweed extract shows promise in treating H. pylori-related diseases, gastric cancer

A unique seaweed extract shows promise for the treatment of Helicobacter pylori-related diseases and gastric cancer, according to new research undertaken at the University of Western Australia.

28 Nov 2015

Incidence of HIV in Europe reaches record high

Results of recent surveillance conducted by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe indicate that the annual number of newly diagnosed HIV infections in Europe reached an all-time high in 2014.

27 Nov 2015

Scientists show how malaria parasites invade the liver

Scientists at the Center for Infectious Disease Research recently uncovered a critical piece in the puzzle of how malaria parasites infect their host. The work, recently published in Science Magazine, reveals the details of how the malaria parasite invades its initial target organ, the liver. Without infection of the liver, the parasites cannot multiply or spread to the blood. Infection of the blood causes illness, spread of the disease, and, ultimately, death.

27 Nov 2015

E. coli can move faster and farther in syrup-like fluids than in water, say Penn researchers

Swimming in a pool of syrup would be difficult for most people, but for bacteria like E. coli, it's easier than swimming in water. Scientists have known for decades that these cells move faster and farther in viscoelastic fluids, such as the saliva, mucus, and other bodily fluids they are likely to call home, but didn't understand why.

26 Nov 2015

Green Cross' GCFlu Quadrivalent approved to protect against four influenza strains in South Korea

Green Cross Corporation, a South Korean biopharmaceutical company, announced today that South Korea's Ministry of Food and Drug Safety has approved GCFLU QUADRIVALENT (Influenza Virus Vaccine) for immunisation of adults to help prevent disease caused by seasonal influenza (flu) virus subtype A and B. GCFlu Quadrivalent is the first locally-manufactured vaccine to cover against four influenza strains.

26 Nov 2015

Chikungunya may cause severe brain infection

The mosquito-borne virus chikungunya may lead to severe brain infection and even death in infants and people over 65, according to a new study that reviewed a chikungunya outbreak on Reunion Island off the coast of Madagascar in 2005-2006.

26 Nov 2015

Disease/Infection News

WHO Prequalification of IVDs Programme accepts Beckman Coulter’s Aquios CL flow cytometer

World Hepatitis Alliance highlights need to recognise impact of coinfection between HIV and viral hepatitis

Bacteriophage therapy: an alternative to antibiotics? An interview Professor Clokie

Larger portion of Africa at high risk for malaria transmission

Synthetic Biologics announces positive results from first SYN-004 Phase 2a study for prevention of CDI, AAD

Novel class of antimicrobials could be effective in fighting drug-resistant MRSA infection

Researchers develop novel computational approach to accelerate search for hepatitis C vaccine

Research highlights importance of controlling hospital and nursing home infection

Combination of antiviral medications can eradicate HCV infection in patients with advanced liver disease

Innovative compound with anti-MRSA qualities may help develop new class of antibiotics

WHO recommends new strategies to treat HIV patients, reduce new infections

Asia-Pacific adolescents face higher risk of HIV, account for 15% of new infections

Scientists can accurately measure microbial growth rates inside gastrointestinal tracts

MPP collaborates with University of Liverpool to accelerate development of HIV nanomedicines

Seaweed extract shows promise in treating H. pylori-related diseases, gastric cancer

Incidence of HIV in Europe reaches record high

Scientists show how malaria parasites invade the liver

E. coli can move faster and farther in syrup-like fluids than in water, say Penn researchers

Green Cross' GCFlu Quadrivalent approved to protect against four influenza strains in South Korea

Chikungunya may cause severe brain infection

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News